Emergent BioSolutions

NCT04067011

Phase 2, Completed, 2019, 210 people, 26 Aug 2019, clinicaltrials.gov

NCT02443623

Phase 4, Completed, 2015, 3,032 people, 14 May 2015, clinicaltrials.gov

NCT01311674

Phase 3, Terminated, 2009, 141 people, 9 Mar 2011, clinicaltrials.gov